International Pediatric Otolaryngology Group (IPOG): Juvenile-onset recurrent respiratory papillomatosis consensus recommendations: International Journal of Pediatric Otorhinolaryngology

C. Lawlor, K. Balakrishnan, S. Bottero, A. Boudewyns, P. Campisi, J. Carter, A. Cheng, A. Cocciaglia, A. DeAlarcon, C. Derkay, P. Fayoux, C. Hart, C. Hartnick, N. LeBoulanger, E. Moreddu, H. Muntz, R. Nicollas, S. Peer, S. Pransky, R. RahbarJ. Russell, M. Rutter, R. Seedat, D. Sidell, R. Smith, M. Soma, J. Strychowsky, D. Thompson, J.-M. Triglia, M. Trozzi, M. Wyatt, G. Zalzal, K.B. Zur, R. Nuss

Research output: Contribution to journalArticlepeer-review


Objectives: To develop consensus recommendations for the evaluation and management of juvenile-onset recurrent respiratory papillomatosis (JORRP) in pediatric patients. Methods: Expert opinion by the members of the International Pediatric Otolaryngology Group (IPOG). The mission of the IPOG is to develop expertise-based consensus recommendations for the management of pediatric otolaryngologic disorders with the goal of improving patient care. The consensus recommendations herein represent the first publication by the group. Results: Consensus recommendations including diagnostic considerations, surgical management, systemic adjuvant therapies, postoperative management, surveillance, and voice evaluation. These recommendations are based on the collective opinion of the IPOG members and are targeted for otolaryngologists, primary care providers, pulmonologists, infectious disease specialists, and any other health care providers that manage patients with JORRP. Conclusions: Pediatric JORRP consensus recommendations are aimed at improving care and outcomes in this patient population. © 2019 Elsevier B.V.
Original languageEnglish
JournalInt. J. Pediatr. Otorhinolaryngol.
Publication statusPublished - 2020


  • 3 indolemethanol
  • antibiotic agent
  • antivirus agent
  • bevacizumab
  • celecoxib
  • cidofovir
  • heat shock protein
  • heat shock protein E7
  • histamine H2 receptor antagonist
  • interferon
  • programmed death 1 receptor
  • proton pump inhibitor
  • steroid
  • unclassified drug
  • Wart virus vaccine
  • adjuvant therapy
  • Article
  • bronchoscopy
  • child
  • consensus
  • Derkay score
  • disease surveillance
  • flexible fiberoptic laryngoscopy
  • gastroesophageal reflux
  • human
  • juvenile onset recurrent respiratory papillomatosis
  • laryngoscopy
  • papillomatosis
  • pathology
  • patient referral
  • pediatric anesthesia
  • pediatric surgery
  • postoperative care
  • priority journal
  • recurrent disease
  • respiratory tract disease
  • scoring system
  • staging
  • thorax radiography
  • treatment duration
  • voice analysis
  • adjuvant chemotherapy
  • health survey
  • papillomavirus infection
  • practice guideline
  • respiratory tract infection
  • Chemotherapy, Adjuvant
  • Child
  • Consensus
  • Humans
  • Papillomavirus Infections
  • Population Surveillance
  • Postoperative Care
  • Referral and Consultation
  • Respiratory Tract Infections

Fingerprint Dive into the research topics of 'International Pediatric Otolaryngology Group (IPOG): Juvenile-onset recurrent respiratory papillomatosis consensus recommendations: International Journal of Pediatric Otorhinolaryngology'. Together they form a unique fingerprint.

Cite this